Clinical evaluation of a novel H. pylori fecal molecular diagnosis kit (multiplex RT-PCR method) for detecting clarithromycin and fluoroquinolones resistance using stool samples

Clinical evaluation of a novel H. pylori fecal molecular diagnosis kit (multiplex RT-PCR method) for detecting clarithromycin and fluoroquinolones resistance using stool samples

BackgroundHelicobacter pylori infection poses a significant global health challenge, exacerbated by rising antibiotic resistance. This study aimed to evaluate a novel multiplex RT-PCR-based fecal diagnostic kit (Cowin Biosciences, Jiangsu, China) for detecting mutations in the 23S rRNA and gyrA gene...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wen-juan Wei, Bang sun He, Bin Lv, Bin Yang, Yong Xie, Zhen yu Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	Helicobacter pylori fecal diagnostic kit clarithromycin resistance fluoroquinolones resistance molecular diagnosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2025.1592612/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular detection of clarithromycin-resistant Helicobacter pylori in stool samples using real-time PCR
by: Menna allah Mohamed, et al.
Published: (2025-08-01)

Clarithromycin Resistance Rates of Helicobacter pylori Infected Gastric Biopsies in Korea
by: Moo-Sang CHONG, et al.
Published: (2025-06-01)

Detection of Clarithromycin Resistance in Helicobacter pylori Using the AllplexTM H. pylori & ClariR Assay and the Ezplex® HP-CLA Real-Time PCR Kit
by: Tae-Woo Kim, et al.
Published: (2025-03-01)

Optimal First-line Eradication Regimens for Helicobacter pylori Infection in Patients with Clarithromycin Resistance: A Pilot Study
by: Min Woo Seo, et al.
Published: (2018-12-01)

Prevalence and Variability of <i>Helicobacter pylori</i> Clarithromycin Resistance Mutations in Pediatric Patients in Poland: A Genotypic Analysis Using the Bosphore Genotyping Kit
by: Tomasz Bogiel, et al.
Published: (2025-03-01)

Comparing Two Treatment Regimens for Helicobacter pylori Eradication: Furazolidone or Clarithromycin?
by: Shirin Rezaei, et al.
Published: (2025-07-01)

A Pilot Study of Helicobacter pylori Eradication Using a Polymerase Chain Reaction-based Test for Clarithromycin Resistance
by: Yun Duk Jung, et al.
Published: (2017-12-01)

Clarithromycin-resistant Helicobacter pylori in Africa: a systematic review and meta-analysis
by: Komla Mawunyo Dossouvi, et al.
Published: (2025-04-01)

Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children
by: Yeliz Çağan-Appak, et al.
Published: (2016-08-01)

Trends of antibiotic resistance of Helicobacter pylori in Moscow
by: Igor V. Maev, et al.
Published: (2025-01-01)

Clinical Efficacy of Gemifloxacin-containing Triple Therapy for First-line Treatment of Helicobacter pylori Infection: A Pilot Study
by: Tae Jun Kim, et al.
Published: (2017-09-01)

Development of polymerase chain reaction coupled with a high-resolution melting technique for detection of Helicobacter pylori clarithromycin resistance
by: Souad Oirdi Zahir, et al.
Published: (2024-08-01)

Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
by: Seon Woo Oh, et al.
Published: (2025-03-01)

Helicobacter pylori 23S rRNA gene mutations associated with clarithromycin resistance in chronic gastritis in Vietnam
by: Van Huy Tran, et al.
Published: (2018-07-01)

Comparison of bismuth and concomitant therapy for H. pylori eradication: a prospective, randomized clinical trial
by: A. Oueslati, et al.
Published: (2025-12-01)

First-Line Prescriptions and Effectiveness of <i>Helicobacter pylori</i> Eradication Treatment in Ireland over a 10-Year Period: Data from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)
by: Sinéad M. Smith, et al.
Published: (2025-07-01)

Recommendations and Adjuvant Therapies to Mitigate Clarithromycin-Resistant Helicobacter pylori-Associated Infections in Africa
by: Dossouvi KM, et al.
Published: (2025-06-01)

GC/MS analysis and potential synergistic effect of mandarin and marjoram oils on Helicobacter pylori
by: Rawah H. Elkousy, et al.
Published: (2022-12-01)

Efficiency of ursodeoxycholic acid in the frameworks of minimization of hepatotoxic potential of eradication therapy of Helicobacter pylori infection
by: D. N. Andreev, et al.
Published: (2021-06-01)

Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective
by: Rania G. Elbaiomy, et al.
Published: (2025-05-01)

Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01)

Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients
by: Guilherme Felga, et al.
Published: (2010-07-01)

Precision Diagnosis of Helicobacter pylori Infection and Its Drug Resistance
by: Bin Tang, et al.
Published: (2025-03-01)

Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance
by: Hafeza Aftab, et al.
Published: (2016-03-01)

Status of Helicobacter pylori Eradication in Japan
by: Gwang Ha Kim
Published: (2017-03-01)

Clinical evaluation of personalized Helicobacter pylori treatment guided by PCR detection from fecal samples: a real-world study
by: Ruolin Peng, et al.
Published: (2025-04-01)

Antimicrobial Resistance of Helicobacter pylori Isolates in Korea
by: Eun Jeong Gong, et al.
Published: (2018-06-01)

Antibiotic resistance of Helicobacter pylori in Mongolia
by: Mandkhai Bolor-Erdene, et al.
Published: (2017-12-01)

Regional features of gastroduodenal disease, associated with Helicobacter pylori infection, in the North Ossetia
by: E. A. Kornienko, et al.
Published: (2014-09-01)

The importance of bismuth-containing quadruple therapy in Helicobacter pylori eradication in an era of increasing antibiotic resistance
by: Yi HU, et al.
Published: (2020-06-01)

Types of 23S Ribosomal RNA Point Mutations Affecting Eradication Rates in Clarithromycin-Based Triple Therapy
by: Gihong Park, et al.
Published: (2023-12-01)

Evaluation of two commercially available rapid stool antigen tests for the diagnosis of Helicobacter pylori infection
by: Mohamed Abd ElAziz Metwally, et al.
Published: (2023-05-01)

Antibiotic-resistance of H. pylori: results of microbiologic regional investigation
by: N. N. Dekhnich, et al.
Published: (2011-03-01)

Beyond antibiotics: probiotics as a promising ally against Helicobacter pylori
by: Lin Yuan, et al.
Published: (2025-07-01)

Antimicrobial resistance in Helicobacter pylori: current situation and management strategy in Vietnam
by: Trung Nam Phan, et al.
Published: (2015-07-01)

Modern approaches to the treatment of peptic ulcer disease and prospects for the use of biological therapy
by: I. V. Koshurba, et al.
Published: (2023-06-01)

Current prospects of fluoroquinolones: pazufloxacin. A review
by: Olga I. Butranova, et al.
Published: (2025-01-01)

Triglyceride-glucose index and mortality risks in Helicobacter pylori-infected patients: a national cohort study
by: Yue Cao, et al.
Published: (2025-02-01)

Silver-hollow mesoporous silica nanoparticles for clarithromycin delivery in an animal model of helicobacter pylori
by: Soroush Mirfakhraee, et al.
Published: (2025-07-01)

Mutational analysis of antibiotic resistance genes in Helicobacter pylori from Ghanaian dyspepsia patients: Implications for treatment strategies
by: Eric Gyamerah Ofori, et al.
Published: (2025-06-01)